Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia

Basit Öğe Kaydı
dc.contributor.authorEskazan, Ahmet Emre
dc.contributor.authorSoysal, Teoman
dc.date.accessioned2024-04-24T17:24:28Z
dc.date.available2024-04-24T17:24:28Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.4274/Tjh.2012.0013
dc.identifier.endpage213en_US
dc.identifier.issn1300-7777
dc.identifier.issn1308-5263
dc.identifier.issue2en_US
dc.identifier.pmid24385789
dc.identifier.startpage211en_US
dc.identifier.urihttps://doi.org/10.4274/Tjh.2012.0013
dc.identifier.urihttps://hdl.handle.net/11468/19689
dc.identifier.volume30en_US
dc.identifier.wosWOS:000320972500020
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofTurkish Journal of Hematology
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keyword]en_US
dc.titleDasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemiaen_US
dc.titleDasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu